Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00556452 · OUTCOME

Regimen Related Toxicities

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen · Source last updated 2017-12-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
toxicities
Interval / dispersion
Not reported
Time frame
two years

What was measured

The incidence of non-hematological toxicities (Common Terminology Criteria for Adverse Events (CTCAE) 3.0) from initiation of conditioning to Day + 30 or toxicities after day +30, possibly, probably or definitely related to conditioning for all patients treated with Clofarabine (independent of dose level).

Groups in this outcome

Clo/Bu4

Experimental: Clo/BU4

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Clo/Bu446

Reported measurements

Liver
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu456Not reportedNot reportedNot reportedNot reported
Gastrointestinal
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu470Not reportedNot reportedNot reportedNot reported
Genito-Urinary
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu44Not reportedNot reportedNot reportedNot reported
Cardiopulmonary
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu410Not reportedNot reportedNot reportedNot reported
Neurologic
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu48Not reportedNot reportedNot reportedNot reported
Skin
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu411Not reportedNot reportedNot reportedNot reported
Other
Values in toxicities · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/Bu43Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        56
    title
    Liver
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        70
    title
    Gastrointestinal
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    title
    Genito-Urinary
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        10
    title
    Cardiopulmonary
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        8
    title
    Neurologic
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        11
    title
    Skin
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        3
    title
    Other
denoms
  1. counts
    1. group Id
      OG000
      value
      46
    units
    Participants
description
The incidence of non-hematological toxicities (Common Terminology Criteria for Adverse Events (CTCAE) 3.0) from initiation of conditioning to Day + 30 or toxicities after day +30, possibly, probably or definitely related to conditioning for all patients treated with Clofarabine (independent of dose level).
groups
  1. description
    Experimental: Clo/BU4
    id
    OG000
    title
    Clo/Bu4
param Type
NUMBER
reporting Status
POSTED
time Frame
two years
title
Regimen Related Toxicities
type
PRIMARY
unit Of Measure
toxicities

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice